Mary K Alderson
Physician in Salt Lake City, UT

License number
Utah 167897-1205
Issued Date
Jun 16, 1982
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Salt Lake City, UT

Personal information

See more information about Mary K Alderson at radaris.com
Name
Address
Phone
Mary Alderson, age 75
4242 S Park Terrace Dr, Salt Lake City, UT 84124
(801) 272-8330

Organization information

See more information about Mary K Alderson at bizstanding.com

Mary K Alderson MD Inc

166 E 5900 S, Salt Lake City, UT 84107

Status:
Inactive
Industry:
Medical Doctor's Office
Phone:
(801) 743-6444 (Phone)
Physical Rehab Medicine, Medical Doctor, Presidents:
Mary K. Alderson President, Medical Doctor, inactive,Carolyn Balbierz Office Manager, inactive,Janet M. Balbierz Physical Rehab Medicine, Medical Doctor, President, inactive

Professional information

Mary Alderson Photo 1

Mary Alderson, Salt Lake City UT

Work:
Western Neurological Assoc Inc
166 E 5900 S, Salt Lake City, UT 84107


Mary K Alderson Photo 2

Dr. Mary K Alderson, Salt Lake City UT - MD (Doctor of Medicine)

Specialties:
Clinical Neurophysiology
Address:
2875 Decker Lake Dr SUITE 550, Salt Lake City 84119
166 E 5900 S SUITE B106, Murray 84107
(801) 743-6444 (Phone), (801) 743-6888 (Fax)
Languages:
English
Education:
Medical School
University of California At Los Angeles
Graduated: 1981


Mary Alderson Photo 3

Deletion In Chromosome 17P11.2-12 Which Causes The Disorder Hereditary Neuropathy With Liability To Pressure Palsies

US Patent:
5645993, Jul 8, 1997
Filed:
May 18, 1995
Appl. No.:
8/443561
Inventors:
Phillip F. Chance - Philadelphia PA
Mary Kathryn Alderson - Salt Lake City UT
Shannon J. Odelberg - Salt Lake City UT
M. William Lensch - Devon PA
Assignee:
University of Utah - Salt Lake City UT
International Classification:
C12Q 168, C12P 1934, C07H 2104, C12N 1500
US Classification:
435 6
Abstract:
A method is disclosed for diagnosing Hereditary Neuropathy with Liability to Pressure Palsies (HNPP). A submicroscopic deletion of about 1. 5 million basepairs on chromosome 17p11. 2 is associated with the disorder in three unrelated pedigrees. The deletion includes all the markers known to map within the Charcot-Marie-Tooth type 1A (CMT1A) duplication. The method involves detecting the presence or absence of the deletion in DNA extracted from a patient sample. The deletion may be detected by Southern analysis or fluorescence in situ hybridization analysis (FISH). Sequences or probes that may be used to detect the deletion are provided, as are components of a kit for diagnosing HNPP.